Literature DB >> 30383966

An Adenosine Triphosphate-Responsive Autocatalytic Fenton Nanoparticle for Tumor Ablation with Self-Supplied H2O2 and Acceleration of Fe(III)/Fe(II) Conversion.

Lu Zhang1, Shuang-Shuang Wan1, Chu-Xin Li1, Lu Xu1, Han Cheng1, Xian-Zheng Zhang1.   

Abstract

Chemodynamic therapy (CDT) can efficiently destroy tumor cells via Fenton reaction in the presence of H2O2 and a robust catalyst. However, it has faced severe challenges including the limited amounts of H2O2 and inefficiency of catalysts. Here, an adenosine triphosphate (ATP)-responsive autocatalytic Fenton nanosystem (GOx@ZIF@MPN), incorporated with glucose oxidase (GOx) in zeolitic imidazolate framework (ZIF) and then coated with metal polyphenol network (MPN), was designed and synthesized for tumor ablation with self-supplied H2O2 and TA-mediated acceleration of Fe(III)/Fe(II) conversion. In the ATP-overexpressed tumor cells, the outer shell MPN of GOx@ZIF@MPN was degraded into Fe(III) and tannic acid (TA) and the internal GOx was exposed. Then, GOx reacted with the endogenous glucose to produce plenty of H2O2, and TA reduced Fe(III) to Fe(II), which is a much more vigorous catalyst for the Fenton reaction. Subsequently, self-produced H2O2 was catalyzed by Fe(II) to generate highly toxic hydroxyl radical (•OH) and Fe(III). The produced Fe(III) with low catalytic activity was quickly reduced to reactive Fe(II) mediated by TA, forming an accelerated Fe(III)/Fe(II) conversion to guarantee efficient Fenton reaction-mediated CDT. This autocatalytic Fenton nanosystem might provide a good paradigm for effective tumor treatment.

Entities:  

Keywords:  Fe(III)/Fe(II) conversion; Fenton reaction; Glucose oxidase; chemodynamic therapy; metal polyphenol network; starvation therapy

Year:  2018        PMID: 30383966     DOI: 10.1021/acs.nanolett.8b03178

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  37 in total

Review 1.  Reactive Oxygen Species-Regulating Strategies Based on Nanomaterials for Disease Treatment.

Authors:  Chenyang Zhang; Xin Wang; Jiangfeng Du; Zhanjun Gu; Yuliang Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-12-20       Impact factor: 16.806

Review 2.  Glucose Metabolism Intervention-Facilitated Nanomedicine Therapy.

Authors:  Zhiyan Li; Xianghui Li; Shichao Ai; Song Liu; Wenxian Guan
Journal:  Int J Nanomedicine       Date:  2022-06-17

3.  Multifunctional Magnetic CuS/Gd2O3 Nanoparticles for Fluorescence/Magnetic Resonance Bimodal Imaging-Guided Photothermal-Intensified Chemodynamic Synergetic Therapy of Targeted Tumors.

Authors:  Minchuan Luo; Hiroshi Yukawa; Kazuhide Sato; Makoto Tozawa; Masato Tokunaga; Tatsuya Kameyama; Tsukasa Torimoto; Yoshinobu Baba
Journal:  ACS Appl Mater Interfaces       Date:  2022-07-24       Impact factor: 10.383

4.  In Situ Polymerized Hollow Mesoporous Organosilica Biocatalysis Nanoreactor for Enhancing ROS-Mediated Anticancer Therapy.

Authors:  Ling Li; Zhen Yang; Wenpei Fan; Liangcan He; Cao Cui; Jianhua Zou; Wei Tang; Orit Jacobson; Zhantong Wang; Gang Niu; Shuo Hu; Xiaoyuan Chen
Journal:  Adv Funct Mater       Date:  2019-11-04       Impact factor: 18.808

5.  TME-activatable theranostic nanoplatform with ATP burning capability for tumor sensitization and synergistic therapy.

Authors:  Yuanli Luo; Bin Qiao; Ping Zhang; Chao Yang; Jin Cao; Xun Yuan; Haitao Ran; Zhigang Wang; Lan Hao; Yang Cao; Jianli Ren; Zhiyi Zhou
Journal:  Theranostics       Date:  2020-05-25       Impact factor: 11.556

6.  Cu-Ferrocene-Functionalized CaO2 Nanoparticles to Enable Tumor-Specific Synergistic Therapy with GSH Depletion and Calcium Overload.

Authors:  Hanjing Kong; Qiang Chu; Chao Fang; Guodong Cao; Gaorong Han; Xiang Li
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

7.  Ellagic acid-Fe@BSA nanoparticles for endogenous H2S accelerated Fe(III)/Fe(II) conversion and photothermal synergistically enhanced chemodynamic therapy.

Authors:  Qingqing Tian; Lu An; Qiwei Tian; Jiaomin Lin; Shiping Yang
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

8.  An open source and reduce expenditure ROS generation strategy for chemodynamic/photodynamic synergistic therapy.

Authors:  Conghui Liu; Yu Cao; Yaru Cheng; Dongdong Wang; Tailin Xu; Lei Su; Xueji Zhang; Haifeng Dong
Journal:  Nat Commun       Date:  2020-04-08       Impact factor: 14.919

Review 9.  Advances in nanomedicine for cancer starvation therapy.

Authors:  Shuangjiang Yu; Zhaowei Chen; Xuan Zeng; Xuesi Chen; Zhen Gu
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

Review 10.  Chemodynamic nanomaterials for cancer theranostics.

Authors:  Jingqi Xin; Caiting Deng; Omer Aras; Mengjiao Zhou; Chunsheng Wu; Feifei An
Journal:  J Nanobiotechnology       Date:  2021-06-28       Impact factor: 10.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.